Drug Database
A07EC02 mesalazine
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Asacol 400mg MR Tablets
- POM Asacol 800mg MR Tablets
- POM Mezavant XL 1200mg, gastro-resistant, prolonged release tablets
- POM Octasa 1600mg modified release tablets
- POM Octasa 1g Suppositories
- POM Octasa 400mg MR Tablets
- POM Octasa 800mg MR Tablets
- POM Pentasa Enema (Mesalazine)
- POM Pentasa Sachet 1g
- POM Pentasa Sachet 2g
- POM PENTASA Sachet 4g prolonged release granules
- POM Pentasa Slow Release Tablets 1g
- POM Pentasa Slow Release Tablets 500mg
- POM Pentasa Suppositories 1g
- POM Salcrozine 1000mg gastro-resistant tablets
- POM Salcrozine 500 mg gastro-resistant tablets
- POM Salofalk 1.5g prolonged-release granules
- POM Salofalk 1000mg prolonged-release granules
- POM Salofalk 1g gastro-resistant tablets
- POM Salofalk 1g Suppositories
- POM Salofalk 1g/actuation Rectal Foam
- POM Salofalk 250mg Tablets
- POM Salofalk 3g prolonged-release granules
- POM Salofalk 500mg gastro-resistant tablets
- POM Salofalk 500mg prolonged-release granules
- POM Salofalk Enema 2g
- POM Salofalk Suppositories 500mg
- POM Zintasa 400mg Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).